You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

OPINION: The U.S. May Never Hit the Herd Immunity Threshold but ...

Half of Americans have now received at least one dose of a Covid-19 vaccine, and with children ages 12 to 15 now eligible for immunizations, the United States appears to be getting the coronavirus pandemic under control. But despite the tremendous progress, it’s still not clear that the nation will ever truly reach the herd immunity threshold — the point at which enough people in a population are immune to a pathogen to limit its spread.

More important, we may not need to achieve that goal in order to escape the pandemic.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Immunity to the Coronavirus May Persist for Years, new studies

 

Immunity to the coronavirus lasts at least a year, possibly a lifetime, improving over time especially after vaccination, according to two new studies. The findings may help put to rest lingering fears that protection against the virus will be short-lived.

Together, the studies suggest that most people who have recovered from Covid-19 and who were later immunized will not need boosters. Vaccinated people who were never infected most likely will need the shots, however, as will a minority who were infected but did not produce a robust immune response.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Two new data studies on demographics of vaccine hesitancy--declining but still there

Two new studies reveal that although COVID-19 vaccine hesitancy has declined in the United States, 35.2% of adults 18 to 39 years and 8.7% of those 65 and older still said they would not partake as of March 2021 and November 2020, respectively.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 6.558 seconds.